Nativeness-constrained diffusion framework for nanobody design
Abstract Aim Nanobodies are single-domain antibodies with promising therapeutic potential, yet accurate complementarity-determining region (CDR) design remains challenging. Methods Existing diffusion-based frameworks such as DiffAb[1] and RFantibody[2] typically generate CDR sequences on fixed scaffolds by enforcing structural and physical constraints, but they neglect evolutionary information intrinsic to antibody repertoires. We propose a scaffold-constrained diffusion framework that integrates a nativeness prior, guiding generation toward sequences that are not only structurally consistent but also evolutionarily plausible. Results By incorporating nativeness-aware constraints during design, our model produces nanobody candidates that better balance physical compatibility with natural repertoire characteristics, achieving improved sequence realism and developability. Conclusion This approach provides a new computational strategy for antibody engineering, enabling more realistic and efficient nanobody design. References 1. Luo S., Su Y., Peng X., Wang S., Peng J., Ma J. ‘Antigen-specific antibody design and optimization with diffusion-based generative models for protein structures.’ Advances in Neural Information Processing Systems 2022. 2. Bennett N.R., Watson J.L., Ragotte R.J., Borst A.J., See D.L., Weidle C., Biswas R., Shrock E.L., Leung P.J.Y., Huang B., Goreshnik I., Ault R., Carr K.D., Singer B., Criswell C., Vafeados D., Garcia Sanchez M., Kim H.M., Vázquez Torres S., Chan S., Baker D. ‘Atomically accurate de novo design of single-domain antibodies.’ bioRxiv 2024.
Authors
- Tao Jiang (ORCID: https://orcid.org/0000-0003-0419-7288)
- Cheuk Shuen Li
- Yinghan Zhang
Institutions
- Chinese University of Hong Kong (HK)
- Biotech Park (IN)
- Novelis (Canada) (CA)
- University of Hong Kong (HK)
Publication Details
- Journal
- Briefings in Bioinformatics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1093/bib/bbaf631.049
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00